WO2002040660A2 - Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae - Google Patents
Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae Download PDFInfo
- Publication number
- WO2002040660A2 WO2002040660A2 PCT/EP2001/012748 EP0112748W WO0240660A2 WO 2002040660 A2 WO2002040660 A2 WO 2002040660A2 EP 0112748 W EP0112748 W EP 0112748W WO 0240660 A2 WO0240660 A2 WO 0240660A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- promoter
- gene
- protein
- cerevisiae
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/70—Vector systems having a special element relevant for transcription from fungi
- C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast
Definitions
- the present invention relates to a promoter, DNA fragments which contain this promoter and their use, in particular in methods for identifying substances which are receptors coupled to G protein show activating or inhibiting effect.
- GPCRs G-protein coupled receptors
- MAPK cascade pheromone-dependent itogen-activated protein kinase cascade
- This property of the yeast can be used to test mammalian GPCRs, in particular human GPCRs, in a yeast model, in order to look for activators or inhibitors of the relevant GPCR or the corresponding one To seek signal transduction pathway, especially since non-species GPCRs can be functionally expressed in the yeast, with a measurable cellular response via the yeast MAPK cascade if the introduced GPCR is activated by a specific ligand and this signal to the MAPK cascade the yeast is passed on.
- the pheromone ⁇ acts directly on the pheromone-dependent MAPK cascade, which regulates the expression of certain S. cerevisiae genes.
- the detection of whether a substance has an activating or inhibiting effect on a GPCR heterologously expressed in S. cerevisiae can be carried out by expressing S. cerevisiae genes which are regulated by the MAPK cascade (“marker genes”).
- the promoters of such marker genes can be used, for example, in connection with a suitable reporter system for the identification of GPCR activators or inhibitors.
- the identification of pheromone-regulated genes can be done on the one hand by using transposon mutagenesis (Ross-Macdonald et al., 1999) or by using DNA microchips, which allow expression analysis for all mRNAs of a cell at a certain point in time (Wodicka et al ., 1997).
- An object of the present invention was to identify another S. cerevisiae promoter which can be activated by pheromone ⁇ and with which a strong expression of the regulated gene can be achieved.
- the invention relates to the promoter of the YNL 279 w gene from S. cerevisiae.
- the invention relates to the promoter with the sequence SEQ ID NO. 4th
- the invention also relates to a recombinant DNA fragment which contains the promoter of the Saccharomyces cerevisiae gene YNL 279 w, which, when functionally linked to a structural gene, regulates its transcription and a recombinant DNA fragment which contains a promoter with the DNA sequence SEQ ID NO. 4 contains.
- the invention relates to a recombinant DNA fragment which contains the promoter YNL 279 w and a structural gene and in which the promoter is functionally linked to the structural gene.
- the structural gene codes for example for a reporter gene or for a protein which is to be produced in large quantities in S. cerevisiae.
- the invention relates to a DNA vector and a recombinant S. cerevisiae cell, which contain such a recombinant DNA fragment.
- a recombinant S. cerevisiae cell preferably expresses no or only small amounts of functionally active endogenous receptors Ste2p and Ste3p.
- the invention also relates to methods for the functional characterization of GPCRs, for the screening of inhibitors and / or activators of GPCRs and methods for the production of proteins in S. cerevisiae.
- a recombinant S. cerevisiae cell which contains a reporter gene under the control of the promoter of the YNL 279 w gene and which expresses a heterologous G protein-coupled receptor; b) the cell is incubated with a substance to be examined and c) the change in transcription of the reporter gene is determined.
- a method for identifying constitutively active mutants of G protein-coupled receptors wherein a) a recombinant S. cerevisiae cell is produced which contains one or more reporter genes under the control of the promoter of the YNL279w gene b) and which contains a mutated heterologous G protein coupled receptor expressed, the modification leads to a constitutively active G-protein coupled receptor, c) the cell is incubated with an activating or inhibiting substance and - d) the change in the transcription of the reporter gene is determined.
- the corresponding endogenous GPCRs, Step2 and / or Step3 are not expressed in the recombinant S. cerevisiae cell, e.g. since these genes have been deleted. This deletion can e.g. as described in Broach Thorner (1996) Nature, 384, 14-16).
- Another embodiment relates to methods for the production of heterologous proteins in S. cerevisiae, the structural gene of the heterologous protein to be expressed being functionally linked to the promoter of the YNL 279 w gene and being expressed under its control.
- the ORF YNL279w showed a strong increase in its expression depending on the time ( Figures 2 and 3). Since the regulation of the transcription or expression of genes generally takes place via regulative sequences 5 'from the starting point of translation, the so-called promoters, the promoters which have such regulative sequences are of particular interest. To identify activators or inhibitors of pharmacologically and medically interesting GPCRs, such inducible or repressible promoters can likewise be cloned into genes or structural genes which represent a suitable reporter system in order to identify substances which have an activating or inhibiting effect after addition point to the reporter system.
- Suitable reporter systems are, for example, the genes of LacZ, luciferase, aequorin, green fluorescent protein (GFP), DsRed, HIS3, URA3, TRP1 and LEU2, but also resistance genes against certain antibiotics, e.g. B. Kanamycin.
- reporter genes can e.g. genes such as lacZ, act in which the effect of certain substances on the MAPK cascade can be demonstrated by discoloration of the cell colonies.
- Reporter genes can also be e.g. are genes that enable the cell to grow under certain selection conditions, e.g. auxotrophic genes.
- DNA constructs which contain the promoter of the YNL279w gene and reporter genes cloned behind are shown in Table 1. These DNA constructs can be used, for example, for the identification of GPCR Activators (agonists) and inhibitors (antagonists) can be used in functional assays.
- the DNA encoding such a reporter gene is fused 3 'to the pheromone-inducible promoter of the ORF YNL279w of the yeast Saccharomyces cerevisae and e.g. cloned into a high-copy vector or iow-copy vector. Yeast cells can then be transformed with these vectors. Likewise, the DNA fused to the promoter can be stably integrated into the yeast genome.
- yeast strains that are genetically manipulated with reporter genes that belong to the group of auxotrophic genes (eg HIS3, URA3, TRP1, LEU2, ADE2 and LYS1) must be mutated for the corresponding gene, ie functionally inactivated.
- auxotrophic genes eg HIS3, URA3, TRP1, LEU2, ADE2 and LYS1
- the yeast promoter YNL 279 w is activated and the expression of the reporter gene regulated by the promoter is increased.
- the promoter of the YNL279w gene is preferably cloned in front of reporter genes such as, for example, HIS, ADE, TRP or LEU, since this combination permits a read-out about the growth of the cells in a correspondingly depleted medium.
- a selected GPCR is activated via a substance to be investigated
- the promoter at the end of the MAPK cascade, YNL279w is activated, and thus expression is regulated by the YNL 279 w promoter regulated reporter gene.
- HIS HIS, ADE, TRP or LEU
- An agonist can be identified by the corresponding S. cerevisiae cells growing in the selection medium.
- a read-out can be carried out using colorimetric or luminometric measurements. Only those cells show chemiluminescence in which the heterologous GPCR was activated by an agonist.
- CAN1 is used as the reporter gene, the cells grow in medium containing canavanine. In the presence of activators (agonists) of a heterologously expressed GPCR, the CAN1 gene is expressed so that the cells no longer grow in the medium containing canavanine. If an antagonist (inhibitor) is added, the cultures grow in this selection medium.
- the screening methods can be carried out on microtiter plates in which yeast cells have been sown which have previously been transformed with the promoter-reporter gene construct (for example a DNA construct from Table 1).
- these cells are transformed with a heterologous GPCR for which an agonist or antagonist is to be found.
- human GPCRs for example adenosine receptors, somatostatin receptors, dopamine receptors, bradykinin receptors, lysolipid receptors, Adrenergic receptors, muscarinic acetylcholine receptors can be used in these procedures.
- the promoter of YNL279w can also be used to identify activators and inhibitors of the pheromone-dependent MAPK cascade. Since the promoter YNL279W is more sensitive to stimulation after pheromone ⁇ treatment than is the case, for example, for the FUS1 promoter, the use of the YNL279w promoter proposed here offers advantages over other screening methods which, e.g. use the FUS1 promoter.
- Figure 4 shows that stimulation of the YNL279w
- Promoter / Aeqourin construct (p415YNL279-AEQ) reacts significantly better than is the case for a promoter element which corresponds to a region from the promoter of the FUS1 gene (here referred to as 4PRE-AEQ).
- Figure 1a Sequence of YNL279w (Genbank AccNr .: Z71555, SEQ ID NO. 3). The start codon ATG is underlined. Sequence areas highlighted in bold represent pheromones responsive elements (PRE).
- Figure 1 b Promoter region (5'-UTR) of YNL279w (SEQ ID NO. 4)
- FIG. 1c Pheromone responsive elements (PRE) in the promoter area of YNL279w
- Figure 2 Expression profile of the Saccharomyces cerevisiae ORF YNL279w after induction with pheromone ⁇ . The changes in gene expression observed are based on the results of investigations with DNA microchips. The changes in the gene expression of the FUS1 gene are shown for comparison.
- Figure 3 Northern blot analysis of the expression profile of the YNL279w gene after stimulation of the yeast cultures with pheromone ⁇ in the yeast mutant sstl.
- Figure 4 Induction of aequorin expression (as relative light units) after stimulation of the yeast cells with the specified concentrations of pheromone ⁇ (B). The values shown in the graph represent the mean for three independently performed tests, the associated individual values are shown in (A).
- the aequorin reporter gene is under the control of the YNL279w promoter.
- 4PRE-AEQ aequorin is under the control of an area (-271 to -1 before start) of the FUS1 gene. Each stimulation attempt was carried out in triplicate.
- Figure 5 Schematic representation of the promoter-reporter gene-vector construct, consisting of the promoter region of YNL279w and the reporter gene aeqourin in the vector p415 (a derivative of vector pRS415: ATCC 87520).
- RNA from these cells was isolated using standard methods (for example Sambrock et al. Molecular Chemistry Press, (Cold Spring Harbor Laboratory 1989) and first strand synthesis was carried out with 30 ⁇ g total RNA each.
- the protocol for first and second strand synthesis as well the purification steps of the generated double-stranded cDNA, the in vitro transcription and the preparation of the cRNA for the hybridization correspond to the protocol of the company Affymetrix Inc. (Santa Clara, CA, USA).
- the ORF YNL279w was identified as one of the most induced ORFs.
- the YNL279w promoter region was amplified from genomic Saccharomyces cerevisiae DNA.
- Example 2 Isolation of the YNL279w Promoter ("Promoter")
- the promoter region of the YNL279w gene was via the primer YNL279F1
- promoter This fragment of the promoter region is hereinafter referred to as "promoter”.
- the amplified promoter region of the YNL279w gene was cloned into the vector p415 before the gene coding for aequorin (see Figure 5; derivative of the vector pRS415, ATCC 87520).
- This construct was transformed into the Saccharomyces cerevisiae strain (Mat a far1 :: hisG sst2 :: ura3 FOA fus1 :: HIS3) using the Li acetate method (Ito et al., 1983).
- Mating factor ⁇ stock solution 100 ⁇ M in 90% methanol
- Coelenterazine stock solution 1 mM in 100% methanol (MOLECULAR PROBES; ref C-2944).
- CaCI 2 stock solution 1M in 1M Tris-HCl solution (100 times diluted in lysis buffer before use)
- Lysis Buffer Yeast Protein Extraction Reagent
- Cismowski MJ Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM, Duzic E. (1999) Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nat Biotechnol 17: 878-83
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01990387A EP1337651B1 (de) | 2000-11-16 | 2001-11-03 | Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae |
CA2429303A CA2429303C (en) | 2000-11-16 | 2001-11-03 | Promoter for the functional characterization of g protein-coupled receptors in the yeast saccharomyces cerevisiae |
KR1020037006630A KR100868665B1 (ko) | 2000-11-16 | 2001-11-03 | 효모 사카로마이세스 세레비시애에서 g-단백질 커플링된수용체의 기능적 특성화를 위한 프로모터 |
AU2002229532A AU2002229532B2 (en) | 2000-11-16 | 2001-11-03 | Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
NZ525863A NZ525863A (en) | 2000-11-16 | 2001-11-03 | Promoter for the functional characterisation of G-protein coupled receptors in the yeast saccharomyces cerevisiae |
IL15583901A IL155839A0 (en) | 2000-11-16 | 2001-11-03 | Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
DE50108920T DE50108920D1 (de) | 2000-11-16 | 2001-11-03 | Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae |
BR0115317-0A BR0115317A (pt) | 2000-11-16 | 2001-11-03 | Promotor para a caracterização funcional de receptores acoplados de proteìna g no lêvedo saccharomyces cerevisae |
JP2002543657A JP4224300B2 (ja) | 2000-11-16 | 2001-11-03 | 酵母サッカロミセスセレビシエにおけるgタンパク質結合型受容体の機能的特徴付けのためのプロモーター |
MXPA03004011A MXPA03004011A (es) | 2000-11-16 | 2001-11-03 | Promotor para la caracterizacion funcional de receptores acoplados a proteina-g en la levadura saccharomyces cerevisiae. |
AU2953202A AU2953202A (en) | 2000-11-16 | 2001-11-03 | Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
IL155839A IL155839A (en) | 2000-11-16 | 2003-05-11 | Promoter for functional characterization of protein-coupled receptors G in yeast SACCHAROMYCES CEREVISIAE |
NO20032158A NO330301B1 (no) | 2000-11-16 | 2003-05-13 | Rekombinant DNA-fragment som inneholder en spesiell promotor, DNA-vektor, rekombinant S. cerevisiae-celle samt fremgangsmater for indentifisering av substanser somviser en aktiverende eller inhiberende virkning pa G-proteinkoblede reseptorer |
CY20061100598T CY1105561T1 (el) | 2000-11-16 | 2006-05-08 | Προαγωγεας για τον λειτουργικο χαρακτηρισμο υποδοχεων συζευγμενων με την πρωτεϊνη g στον ζυμομυκητα saccharomyces cerevisiae |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10056899.8 | 2000-11-16 | ||
DE10056899A DE10056899A1 (de) | 2000-11-16 | 2000-11-16 | Promotor zur funktionellen Charakterisierung von G-Protein gekoppelten Rezeptoren in der Hefe Saccharomyces cerevisiae |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002040660A2 true WO2002040660A2 (de) | 2002-05-23 |
WO2002040660A3 WO2002040660A3 (de) | 2003-03-13 |
Family
ID=7663576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012748 WO2002040660A2 (de) | 2000-11-16 | 2001-11-03 | Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae |
Country Status (19)
Country | Link |
---|---|
US (1) | US6602699B2 (de) |
EP (1) | EP1337651B1 (de) |
JP (1) | JP4224300B2 (de) |
KR (1) | KR100868665B1 (de) |
AT (1) | ATE317444T1 (de) |
AU (2) | AU2953202A (de) |
BR (1) | BR0115317A (de) |
CA (1) | CA2429303C (de) |
CY (1) | CY1105561T1 (de) |
DE (2) | DE10056899A1 (de) |
DK (1) | DK1337651T3 (de) |
ES (1) | ES2257459T3 (de) |
IL (2) | IL155839A0 (de) |
MX (1) | MXPA03004011A (de) |
NO (1) | NO330301B1 (de) |
NZ (1) | NZ525863A (de) |
PT (1) | PT1337651E (de) |
WO (1) | WO2002040660A2 (de) |
ZA (1) | ZA200303120B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010091692A3 (en) * | 2009-04-30 | 2010-10-21 | H. Lundbeck A/S | Constitutively active mutants of gpcr 88 and uses thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7445925B2 (en) * | 2001-10-27 | 2008-11-04 | Sanofi-Aventis Deutschland Gmbh | Aequorin as a reporter gene in yeast |
DE10233516A1 (de) * | 2002-07-23 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Identifizierung von Substanzen |
US7872115B2 (en) * | 2004-09-15 | 2011-01-18 | Schering Corporation | Reporter assay screens for protein targets in Saccharomyces cerevisiae |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5063154A (en) * | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
WO1999051620A1 (en) * | 1998-04-03 | 1999-10-14 | Invitrogen Corporation | Libraries of expressible gene sequences |
WO2000012704A2 (en) * | 1998-09-01 | 2000-03-09 | Basf Aktiengesellschaft | Enhanced functional expression of g protein-coupled receptors |
WO2001016378A2 (en) * | 1999-09-01 | 2001-03-08 | Whitehead Institute For Biomedical Research | Chromosome-wide analysis of protein-dna interactions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591576A (en) * | 1993-08-16 | 1997-01-07 | American Cyanamid Company | Sterol Δ14 reductase screen |
-
2000
- 2000-11-16 DE DE10056899A patent/DE10056899A1/de not_active Ceased
-
2001
- 2001-11-03 KR KR1020037006630A patent/KR100868665B1/ko not_active IP Right Cessation
- 2001-11-03 IL IL15583901A patent/IL155839A0/xx unknown
- 2001-11-03 AU AU2953202A patent/AU2953202A/xx active Pending
- 2001-11-03 AU AU2002229532A patent/AU2002229532B2/en not_active Ceased
- 2001-11-03 EP EP01990387A patent/EP1337651B1/de not_active Expired - Lifetime
- 2001-11-03 ES ES01990387T patent/ES2257459T3/es not_active Expired - Lifetime
- 2001-11-03 BR BR0115317-0A patent/BR0115317A/pt not_active IP Right Cessation
- 2001-11-03 MX MXPA03004011A patent/MXPA03004011A/es active IP Right Grant
- 2001-11-03 DE DE50108920T patent/DE50108920D1/de not_active Expired - Lifetime
- 2001-11-03 CA CA2429303A patent/CA2429303C/en not_active Expired - Fee Related
- 2001-11-03 JP JP2002543657A patent/JP4224300B2/ja not_active Expired - Fee Related
- 2001-11-03 WO PCT/EP2001/012748 patent/WO2002040660A2/de active IP Right Grant
- 2001-11-03 DK DK01990387T patent/DK1337651T3/da active
- 2001-11-03 AT AT01990387T patent/ATE317444T1/de active
- 2001-11-03 NZ NZ525863A patent/NZ525863A/en not_active IP Right Cessation
- 2001-11-03 PT PT01990387T patent/PT1337651E/pt unknown
- 2001-11-07 US US09/986,121 patent/US6602699B2/en not_active Expired - Fee Related
-
2003
- 2003-04-23 ZA ZA200303120A patent/ZA200303120B/en unknown
- 2003-05-11 IL IL155839A patent/IL155839A/en not_active IP Right Cessation
- 2003-05-13 NO NO20032158A patent/NO330301B1/no not_active IP Right Cessation
-
2006
- 2006-05-08 CY CY20061100598T patent/CY1105561T1/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5063154A (en) * | 1987-06-24 | 1991-11-05 | Whitehead Institute For Biomedical Research | Pheromone - inducible yeast promoter |
WO1999051620A1 (en) * | 1998-04-03 | 1999-10-14 | Invitrogen Corporation | Libraries of expressible gene sequences |
WO2000012704A2 (en) * | 1998-09-01 | 2000-03-09 | Basf Aktiengesellschaft | Enhanced functional expression of g protein-coupled receptors |
WO2001016378A2 (en) * | 1999-09-01 | 2001-03-08 | Whitehead Institute For Biomedical Research | Chromosome-wide analysis of protein-dna interactions |
Non-Patent Citations (2)
Title |
---|
DATABASE EMBL [Online] 6. Mai 1996 (1996-05-06) retrieved from EBI Database accession no. Z71555 XP002217914 * |
PAUSCH M H: "G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery" TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, Bd. 15, Nr. 12, 1. Dezember 1997 (1997-12-01), Seiten 487-494, XP004097426 ISSN: 0167-7799 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010091692A3 (en) * | 2009-04-30 | 2010-10-21 | H. Lundbeck A/S | Constitutively active mutants of gpcr 88 and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
MXPA03004011A (es) | 2003-08-19 |
CY1105561T1 (el) | 2010-07-28 |
EP1337651B1 (de) | 2006-02-08 |
ATE317444T1 (de) | 2006-02-15 |
DE50108920D1 (de) | 2006-04-20 |
NZ525863A (en) | 2005-04-29 |
JP4224300B2 (ja) | 2009-02-12 |
ES2257459T3 (es) | 2006-08-01 |
IL155839A0 (en) | 2003-12-23 |
KR100868665B1 (ko) | 2008-11-13 |
US20030059779A1 (en) | 2003-03-27 |
AU2002229532B2 (en) | 2007-06-28 |
BR0115317A (pt) | 2003-09-02 |
ZA200303120B (en) | 2004-04-22 |
NO20032158D0 (no) | 2003-05-13 |
CA2429303A1 (en) | 2003-05-16 |
AU2953202A (en) | 2002-05-27 |
KR20030051831A (ko) | 2003-06-25 |
CA2429303C (en) | 2011-01-11 |
WO2002040660A3 (de) | 2003-03-13 |
JP2004513656A (ja) | 2004-05-13 |
NO20032158L (no) | 2003-07-15 |
DE10056899A1 (de) | 2002-05-29 |
NO330301B1 (no) | 2011-03-28 |
DK1337651T3 (da) | 2006-06-12 |
IL155839A (en) | 2009-06-15 |
EP1337651A2 (de) | 2003-08-27 |
PT1337651E (pt) | 2006-06-30 |
US6602699B2 (en) | 2003-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69831083T2 (de) | Reprimiertes trans-aktivatorsystem zur charakterisierung von protein-protein interaktionen | |
Engebrecht et al. | MER1, a yeast gene required for chromosome pairing and genetic recombination, is induced in meiosis | |
EP1025253B2 (de) | Positiv-negativ-selektion bei der homologen rekombination | |
DE69533420T2 (de) | Für carboxypeptidase kodierendes gen aus aspergillus niger | |
EP2228456B1 (de) | Selektion kodierender Nukleinsäure-Konstrukte auf Abwesenheit von Frameshift-Mutationen | |
EP1337651B1 (de) | Promotor zur funktionellen charakterisierung von g-protein gekoppelten rezeptoren in der hefe saccharomyces cerevisiae | |
DE3131034A1 (de) | "autonom replizierendes eukaryotisches dna-segment" | |
DE69936867T2 (de) | Dns sequenz, verfahren für dessen nachweis und herstellung und benutzung | |
DE69627787T2 (de) | Actinomyceten-Promotor | |
EP1504103B1 (de) | Promotoren mit veränderter transkriptionseffizienz aus der methylotrophen hefe hansenula polymorpha | |
DE69435058T2 (de) | Multicloning-vektor, expressionsvektor und herstellung von fremdproteinen unter verwendung des expressionsvektors | |
DE69233339T2 (de) | Expressionsteigerung durch Gentargeting in endogene Retrovirus-ähnliche Sequenzen | |
DE60226056T2 (de) | Aequorin als reportergen in hefe | |
DE60013829T2 (de) | Pichia methanolica glyceraldehyd-3-phosphat-dehydrogenase-1-promoter und -terminator | |
EP1280893B1 (de) | Verfahren zum herstellen von proteinen in einer hefe der gattung arxula und dafür geeignete promotoren | |
DE69937806T2 (de) | Methode zum identifizieren von inhibitoren der ipc-synthase | |
DE4342769A1 (de) | Isolierung und Klonierung von für ein RNA-bindendes Protein kodierender cDNA sowie Untersuchung RNA-bindender Proteine | |
WO1999064567A1 (de) | Transformierte zell-linien, die heterologe g-protein-gekoppelte rezeptoren exprimieren | |
JP2000116392A (ja) | 新規ベクタ― | |
EP0536646A2 (de) | Neue recombinante Viren, deren Verwendung und deren Herstellung | |
DE69433222T2 (de) | Mutanter AOX2-Promotor | |
WO1995014773A1 (de) | Neue transkriptionsfaktor-mutanten und ihre verwendung | |
DE4408690A1 (de) | Testverfahren zur Identifizierung von Substanzen, die auf Endothelinrezeptoren wirken | |
JP2002534127A (ja) | 酵母におけるトランス−作用因子 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001990387 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/03120 Country of ref document: ZA Ref document number: 200303120 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/004011 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 707/CHENP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 155839 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 525863 Country of ref document: NZ Ref document number: 2002229532 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002543657 Country of ref document: JP Ref document number: 1020037006630 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2429303 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037006630 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001990387 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 525863 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 525863 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001990387 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002229532 Country of ref document: AU |